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Background: Enteroviruses (EVs) are the leading cause of aseptic meningitis worldwide. Detection of enteroviral
RNA in clinical specimens has been demonstrated to improve the management of patient care, especially that of
neonates and young children.
Findings: To establish a sensitive and reliable assay for routine laboratory diagnosis, we compared the sensitivity
and specificity of the GeneXpert Enterovirus Assay (GXEA) with that of the reverse transcription polymerase
chain reaction (RT-PCR) based assay referred to as real-time one step RT-PCR (RTo-PCR). The sensitivity/specificity
produced by GXEA and RTo-PCR were 100%/100% and 65%/100%, respectively.
Conclusions: Both methods evaluated in this article can be used for detection of enterovirus in clinical specimens
and these nucleic acid amplification methods are useful assays for the diagnosis of enteroviral infection.
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Enteroviruses (EVs) are the most common cause of asep-
tic meningitis in children and adults and may cause up
to 90% of aseptic meningitis cases [1]. The rapid and ac-
curate diagnosis of human enteroviral infections can re-
duce the use of antibiotics, duration of hospitalization,
and financial costs [2-6]. Methods involving the amplifi-
cation of nucleic acids have replaced traditional culture-
based methods as the gold standard for the detection
of EVs in cerebrospinal fluid (CSF) because of their
increased sensitivity and speed. Routine diagnostic
methods using real-time reverse transcription poly-
merase chain reaction (RT-PCR) have been developed
over the past 15 years in an attempt to improve experts’
ability to detect EVs in CSF [7]. The latest development in* Correspondence: junewoo1213@korea.kr; bh4400@daum.net
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unless otherwise stated.the diagnosis of enteroviral meningitis is the GeneXpert
Enterovirus Assay (GXEA; Cepheid, Sunnyvale, CA), a
fully automated real-time multiplex RT-PCR assay. GXEA
is the only assay approved by the U.S. Food and Drug
Administration for the qualitative detection of enteroviral
RNA in CSF. The GeneXpert system is a closed, unit-
dose, molecular, microfluidics instrument that performs
extraction, processing, and real-time RT-PCR, as well as
the detection of nucleic acid targets. The system uses
single-use cartridges that contain all of the reagents re-
quired for sample processing and PCR [8-10].
We compared the speed and reliability of GXEA with
that of real-time one step RT-PCR (RTo-PCR), a method
described in a previous publication by Verstrepen et al.,
that is routinely used for the detection of enteroviral
RNA in CSF [11].
To determine the detection range of RTo-PCR using a
TaqMan-formatted probe, we obtained five reference
strains belonging to different serotypes (enterovirus 71,his is an Open Access article distributed under the terms of the Creative
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poliovirus 1) from the American Type Culture Collection
(ATCC) and used these strains to determine the detection
limit and positive control of RTo-PCR.
To assess the applicability of GXEA to detect EVs in
clinical specimens with a low viral load, from June to
September of 2008, we collected 109 CSF specimens
from patients with aseptic meningitis. We had approval
of an Institutional Review Board (IRB) through the
Korean National Institute of Health. We analyzed these
specimens by GXEA according to the manufacturer’s in-
structions using 140 μL of each sample. For the RTo-
PCR assay, viral RNA was extracted using silica-coated
magnetic beads based on Boom’s method in combination
with an automatic liquid handling machine (TECAN,
Männedorf, Switzerland) [12]. The TaqMan format
RTo-PCR for the detection of EVs was performed ac-
cording to the previously optimized reaction conditions
[11]. Both assays targeted the 5′ noncoding region of the
EV genome, which is commonly used in routine diag-
nostic assays because of its highly conserved genetic
identity [11,13].
GXEA and RTo-PCR detected the presence of entero-
virus in test samples from five reference strains, of dif-
ferent serotypes, with the limits of detection ranging
from 2 to 0.05 TCID50/mL for GXEA and from 1 to 0.01
TCID50/mL for RTo-PCR (data not shown). Next, we
compared the detection efficiency of the recently devel-
oped GXEA molecular diagnostic system, which is based
on the concept of a “lab on a chip,” with that of RTo-
PCR, using the CSF samples collected in 2008 from pa-
tients with meningitis. Of the 109 clinical samples
assayed by GXEA and RTo-PCR, 66 and 43 were deter-
mined to be positive, respectively (Table 1). All of the
samples found to be positive by RTo-PCR were also de-
tected by GXEA, with no false positives. In the detection
of enteroviral RNA from CSF, the sensitivities/specific-
ities of RTo-PCR and GXEA were 65%/100% and 100%/
100%, respectively. The GXEA results were in agreement
with those produced by RTo-PCR in 78.9% of cases.
To compare the detection efficiencies of the assays
used in this study, we used the mean Ct values from the
positive samples; specifically, we divided the values from
the GXEA-positive samples by those from the RTo-
PCR-positive samples, and the values from the GXEA-Table 1 Results of RTo-PCR assay and GXEA for 109
clinical samples from patients with aseptic meningitis
No. of positive results/
total no. of samples
No. of negative results/
total no. of samples
GXEAa 66/109 43/109
RTo-PCR assayb 43/109 66/109
aGeneXpert Enterovirus Assay.
bReal-time one step RT-PCR.positive samples by those from the RTo-PCR-negative
samples (Figure 1). The mean Ct values from the GXEA-
and RTo-PCR-positive samples (GXEA(+)/TaqMan(+))
and those from the GXEA-positive, RTo-PCR-negative
samples (GXEA(+)/TaqMan(−)) were 32.38 and 34.85,
respectively. According to our results, GXEA is more
sensitive than RTo-PCR. This can be explained by the
distribution of the Ct values for the positive speci-
mens, which is an indirect measure of the viral load,
as shown in Figure 1.
The sensitivity of GXEA was higher than that of RTo-
PCR, and GXEA did not produce discordant positive
results when conduced on the RTo-PCR-positive speci-
mens. The mean Ct values for the GXEA-only positive
samples (GXEA(+)/TaqMan(−)) were about 2.5 fold
higher than those for the samples found to be positive
by both assays (GXEA(+)/TaqMan(+)); thus, GXEA is at
least 10 times more sensitive than routine RTo-PCR.
The discrepancy observed in this study amomg theFigure 1 Comparison of the distributed threshold cycle (Ct)
values. The Ct values of samples identified as positive by both
GeneXpert Enterovirus Assay (GXEA) and real-time one-step RT-PCR
(RTo-PCR) (GXEA(+)/TaqMan(+):●) and the Ct values of GXEA positive
but RTo-PCR assay negative (GXEA(+)/TaqMan(+):■) samples were
graphed, respectively. The Ct mean value and standard deviation
(S.D.) of double-positive samples was 32.38 and 2.48 respectively.
The Ct mean value and S.D. of GXEA positive but RTo-PCR negative
samples was 34.85 and 2.18 respectively.
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load (n = 20) indicates a higher than expected inci-
dence of CSF specimens from patients with viral men-
ingitis with viral titers below the detection limit of
routine molecular assays. Evidently, qualitative tests
for the detection of EVs can be influenced by the de-
tection limit of the molecular assay being used.
The GXEA system produced a lower Ct value than
RTo-PCR. This may be explained by the fact that GXEA
utilizes single-use cartridges that contain all of the re-
agents required for sample processing. Thus, the entire
amount of extracted RNA is used in GXEA, while, in
RTo-PCR, the amount of RNA used may be 10-fold
lower. The sensitivity of an assay depends in part on the
total amount of RNA used.
Viruses, controls, and clinical samples
Five reference strains belonging to distinct genotypes
[enterovirus 71 (E71), coxsackievirus B2 (CVB2), echo
30 (E30), coxsackievirus A24 (CVA24), and poliovirus
type 1 (P1)] were obtained from the American Type
Culture Collection (ATCC). Infectivity of viruses was
assayed by microplates in serial 10-fold dilutions (from
10-4 to 10-10) in quadruplicate (four wells per dilution).
TCID50 titers were calculated according to the Kärber
method [14]. In total, 109 clinical specimens were col-
lected from patients with suspected viral meningitis be-
tween June and September 2008.
Extraction of viral RNA
RNA was extracted from 150 μL samples with the GM
Viral Nucleic Acid Extraction Kit (GreenMate Biotech
Corp, Korea), according to the manufacturer’s protocol,
using automated machines for liquid handling (Tecan,
Switzerland). The GM Viral Nucleic Acid Extraction Kit
uses a silica-based extraction method [12]. RNA was
then recovered in 50 μL of nuclease-free water. It was
used immediately or stored at -70°C.
One-step real-time RT–PCR
Real-time one step RT-PCR (RTo-PCR) was performed
using an ABI Prism 7900HT sequence detection system
(Applied Biosystems). Viral RNA was amplified in 25 μL
reactions using RT–PCR master mix (AgPath-ID one-
step RT–PCR Kit; Ambion, CA). Reactions were incu-
bated at 45°C for 15 min, and then at 95°C for 10 min,
followed by 45 cycles of 95°C for 15 s and 60°C for 40 s.
Viral nucleic acid amplification is being developed as a
diagnostic procedure to detect enteroviral infections
[15]. There is an urgent need to devise standardized
methods, utilizing commercialized kits, that can supple-
ment or replace the diagnostic tests that are often devel-
oped in-house, and that are, therefore, inconsistent in
their sensitivity and specificity. The GeneXpert machineand assay kit, which has been approved by the U.S.
Food and Drug Administration for the detection of
EVs, produces rapid and highly sensitive results from
CSF samples [9,10].
These innovative tests, based on state-of-the-art tech-
nologies, provide the means by which to achieve more
accurate clinical laboratory results and, therefore, better
patient care, when attempting to diagnose or rule out
sepsis.
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